Detection of Melanoma Nodal Metastases; Differences in Detection Between Elderly and Younger Patients Do Not Affect Survival

por Kruijff, S., Bastiaannet, E., Suurmeijer, A. J. H., Hoekstra, H. J.
Publicado 2010

Suitability of the Cellient(TM) cell block method for diagnosing soft tissue and bone tumors

por Song, W., van Hemel, B. M., Suurmeijer, A. J. H.
Publicado 2018

S-100B Concentrations Predict Disease-Free Survival in Stage III Melanoma Patients

por Kruijff, S., Bastiaannet, E., Muller Kobold, A. C., van Ginkel, R. J., Suurmeijer, A. J. H., Hoekstra, H. J.
Publicado 2009

Prognostic value of the standardized uptake value for (18)F-fluorodeoxyglucose in patients with stage IIIB melanoma

por Bastiaannet, E., Hoekstra, O. S., de Jong, J. R., Brouwers, A. H., Suurmeijer, A. J. H., Hoekstra, H. J.
Publicado 2012

Erratum to: S-100B Concentrations Predict Disease-Free Survival in Stage III Melanoma Patients

por Kruijff, S., Bastiaannet, E., Muller Kobold, A. C., van Ginkel, R. J., Suurmeijer, A. J. H., Hoekstra, H. J.
Publicado 2010

Use of S-100B to Evaluate Therapy Effects during Bevacizumab Induction Treatment in AJCC Stage III Melanoma

por Kruijff, S., Bastiaannet, E., Brouwers, A. H., Nagengast, W. B., Speijers, M. J., Suurmeijer, A. J. H., Hospers, G. A., Hoekstra, H. J.
Publicado 2011

Abundant Fas expression by gastrointestinal stromal tumours may serve as a therapeutic target for MegaFasL

por Rikhof, B, van der Graaf, W T A, Meijer, C, Le, P T K, Meersma, G J, de Jong, S, Fletcher, J A, Suurmeijer, A J H
Publicado 2008

Key Roles for MYC, KIT and RET signaling in secondary angiosarcomas

por Styring, E, Seinen, J, Dominguez-Valentin, M, Domanski, H A, Jönsson, M, von Steyern, F V, Hoekstra, H J, Suurmeijer, A J H, Nilbert, M
Publicado 2014